Cargando…

Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate

Mesenchymal Stem Cells (MSCs) have been identified in prostate cancer, raising the critical question of their physical and temporal source. Therefore, MSCs were quantified and characterized in benign and malignant prostate tissue representing different disease states and a wide range of age groups f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brennen, W. Nathaniel, Zhang, Baohui, Kulac, Ibrahim, Kisteman, L. Nelleke, Antony, Lizamma, Wang, Hao, Meeker, Alan K., De Marzo, Angelo M., Garraway, Isla P., Denmeade, Samuel R., Isaacs, John T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564518/ https://www.ncbi.nlm.nih.gov/pubmed/28493842 http://dx.doi.org/10.18632/oncotarget.17362

Ejemplares similares

Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer
por: Brennen, W. Nathaniel, et al.
Publicado: (2012)

PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer
por: Rogers, Oliver C., et al.
Publicado: (2018)

Concise Review: Mesenchymal Stem Cell‐Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise
por: Krueger, Timothy E. G., et al.
Publicado: (2018)

Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancer
por: Akinboye, Emmanuel S., et al.
Publicado: (2019)

Mipsagargin: The Beginning—Not the End—of Thapsigargin Prodrug-Based Cancer Therapeutics
por: Isaacs, John T., et al.
Publicado: (2021)

Role of androgen receptor splice variant 7 (AR-V7) in prostate cancer resistance to 2(nd) generation androgen receptor signaling inhibitors
por: Zhu, Yezi, et al.
Publicado: (2020)

The BRD4–NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma
por: Durall, R. Taylor, et al.
Publicado: (2023)

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
por: Brennen, W. Nathaniel, et al.
Publicado: (2021)

A Phase I Study to Assess the Safety and Cancer‐Homing Ability of Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer
por: Schweizer, Michael T., et al.
Publicado: (2019)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2016)

Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies
por: Stoll, Gautier, et al.
Publicado: (2015)

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2015)

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
por: Sena, Laura A., et al.
Publicado: (2022)

Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation
por: Lin, Shan, et al.
Publicado: (2016)

In Reply
por: Brennen, W. Nathaniel, et al.
Publicado: (2019)

Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy
por: Xu, Hui, et al.
Publicado: (2015)

Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis
por: Gao, Yang, et al.
Publicado: (2016)

Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations
por: Watanabe-Smith, Kevin, et al.
Publicado: (2017)

Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment
por: Isaacs, John T., et al.
Publicado: (2014)

EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models
por: Venugopalan, Abhilash, et al.
Publicado: (2016)

Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells
por: Spender, Lindsay C., et al.
Publicado: (2016)

Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study
por: Karlsson, Questa, et al.
Publicado: (2021)

Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation
por: Keitel, Ulrike, et al.
Publicado: (2014)

CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice
por: Sakakibara, Keiichi, et al.
Publicado: (2017)

p27(kip1) expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms
por: Pellizzari, Ilenia, et al.
Publicado: (2016)

Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis
por: Lagunas, Angelica M., et al.
Publicado: (2017)

Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor
por: Yingling, Jonathan M., et al.
Publicado: (2017)

AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts
por: Pelletier, Joffrey, et al.
Publicado: (2015)

Neoplastic Transformation of Human Mesenchymal Stromal Cells Mediated via LIN28B
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2019)

Na(+)/H(+) exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells
por: Amith, Schammim Ray, et al.
Publicado: (2016)

Expression of a germline variant in the N-terminal domain of the human DNA glycosylase NTHL1 induces cellular transformation without impairing enzymatic function or substrate specificity
por: Marsden, Carolyn G., et al.
Publicado: (2020)

Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
por: Bansal, Nidhi, et al.
Publicado: (2015)

p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3
por: Hünten, Sabine, et al.
Publicado: (2015)

The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells
por: Sullivan, Kelly E., et al.
Publicado: (2017)

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial
por: von Einem, Jobst C., et al.
Publicado: (2017)

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
por: Liu, Qinghai, et al.
Publicado: (2009)

Peripheral Inflammation is Associated with Altered Substantia Nigra Activity and Psychomotor Slowing in Humans
por: Brydon, Lena, et al.
Publicado: (2008)

Chronic Activation of Corticotropin-Releasing Factor Type 2 Receptors Reveals a Key Role for 5-HT1A Receptor Responsiveness in Mediating Behavioral and Serotonergic Responses to Stressful Challenge
por: Neufeld-Cohen, Adi, et al.
Publicado: (2012)

Hostility and Cellular Aging in Men from the Whitehall II Cohort
por: Brydon, Lena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3s78mpmi27hnmol0mvoqi2covs